MedPath

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO COMPARE THE EFFICACY OF PROPRANOLOL WITH PLACEBO FOR THE PROPHYLAXIS OF MIGRAINE IN CHILDRE

Phase 3
Completed
Conditions
Migraine without aura
Migraine
Propranolol
Placebo
Registration Number
TCTR20200621001
Lead Sponsor
Maulana Azad Medical College, Bahadur shah zafar marg, New Delhi.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

•Diagnosed with Migraine without aura as per International Classification of Headache Disorders, 3rd Edition (ICHD-3) (Annexure-4).
•Either >3 missed school days or >3 severe headaches per month.

Exclusion Criteria

•Diagnosed with another co-existent headache disorder;
•Co-existent asthma or cardiovascular disease that preclude the use of propranolol;
•Receiving prophylaxis with any medication, currently or in past 3 months;
•Receiving any anti-convulsant drug, currently or in past 3 months; and
•Receiving Complementary and alternative medications (CAM).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of migraine attacks 3 months Headache diary
Secondary Outcome Measures
NameTimeMethod
the frequency of migraine attacks 3 months manual
© Copyright 2025. All Rights Reserved by MedPath